Aratana

United States Founded: 2010 • Age: 16 yrs Listed Acquired By Elanco
Therapeutics to treat osteoarthritis, inappetence, cancer, viral infections in pets.

About Aratana

Aratana is a Healthcare company based in United States founded in 2010, and was acquired by Elanco in April 2019. Therapeutics to treat osteoarthritis, inappetence, cancer, viral infections in pets. Aratana has raised $47 million across 6 funding rounds from investors including Elanco, Square 1 Bank and Oxford Finance. Aratana has completed 2 acquisitions, including Okapi Sciences and Vet Therapeutics. Its focus areas include Veterinary Healthcare Providers.

Company details

Aratana Therapeutics was founded in 2010 in the United States as a developer of therapeutics for companion animals. Drugs in development stages are targeted at alleviating pain and inflammation from osteoarthritis in dogs and cats. Additional medicines are being created to address inappetence, cancer, and viral infections. Operations focus on advancing these treatments within the pet healthcare sector.

  • Headquarters United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website aratana.com
  • Acquired by Elanco (Apr 2019)
Key Metrics
  • Total Equity Funding
    $47M (USD)

    in 6 rounds

  • Latest Funding Round
    $40M (USD), Debt – Conventional

    Oct 2015

  • Investors
    Elanco

    & 8 more

  • Investments & Acquisitions
  • Acquired by
    Elanco

    (Apr 2019)

Funding Insights of Aratana

Aratana has successfully raised a total of $47M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $40 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $47M
  • Total Rounds 6
  • Last Round Debt – Conventional β€” $40M
  • First Round $20M

    (Jan 2011)

  • Investors Count 8

All 6 funding rounds of Aratana with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2015$40MDebt – Conventional––
May 2015$56,000Grant––
Oct 2013$29.75MPost-IPO––
–
Jan 2013$12MSeries C––
–
Dec 2011$15MSeries B–Kauffman Foundation, Cultivian Sandbox
Jan 2011$20MSeries A–MPM Capital, Kansas Bioscience Authority
–
Valuation history

9 investors in total: 9 institutional.

Investors in Aratana

Aratana has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Elanco, Square 1 Bank and Oxford Finance.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture debt firm focused on the life sciences sector
2002oxfordfinance.comAlexandria, United States
cultiviansbx.com
avalonbioventures.com
kansasbioauthority.org
Venture debt, treasury, and cash management services are provided.
2005square1bank.comDurham, United States
Invests in biotech firms developing life-saving drugs and technologies.
mpmcapital.com
Funding is provided for education, workforce, and entrepreneurship initiatives.
1966kauffman.orgKansas City, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Veterinary food and medicines products are provided for animal health.
1954elanco.comGreenfield, United States
Premium access

Investor details for Aratana

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aratana

Aratana has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Okapi Sciences and Vet Therapeutics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Limited information available
okapi-sciences.comLeuven, Belgium2007Jan 2014$44M
Antibody-based therapies for companion animal cancer treatment are developed.
vettherapeutics.comDel Mar, United States2009Oct 2013$30M
Premium access

Complete acquisition details for Aratana

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Aratana

7 dated milestones of Aratana across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aratana is founded.
  2. Funding First funding round of $20.0M.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Vet Therapeutics.
  5. Acquisition Acquires Okapi Sciences.
  6. Funding Latest funding round, Debt – Conventional, of $40.0M.
  7. Exit Acquired by Elanco.

Top companies in Veterinary Healthcare & Products

3 companies that operate in the same segment as Aratana (Veterinary Healthcare & Products) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
A chain of veterinary hospitals is operated nationwide.
1986Los Angeles, California, United StatesUSD 5.96 B29,000
Chain of veterinary hospital
2012Westport, United States
Diagnostics and pharmaceuticals for companion animals are developed.
2015Ann Arbor, Michigan, United StatesUSD 32.03 M152
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aratana

Aratana was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Aratana is headquartered in United States.

Aratana is a funded company, having raised a total of $47M across 6 funding rounds to date. The company's 1st funding round was a Series A of $20M, raised on Jan 2011.

Aratana Therapeutics was founded in 2010 in the United States as a developer of therapeutics for companion animals. Drugs in development stages are targeted at alleviating pain and inflammation from osteoarthritis in dogs and cats. Additional medicines are being created to address inappetence, cancer, and viral infections. Operations focus on advancing these treatments within the pet healthcare sector.

Aratana has made 2 acquisitions, including Okapi Sciences, and Vet Therapeutics.

Aratana has 9 investors. Key investors include Elanco, Square 1 Bank, Oxford Finance, European Union, and Kauffman Foundation.

Yes. Aratana was acquired by Elanco in April 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available